MD Anderson Cancer Center and Ascentage Pharma announce strategic alliance in cancer drug development
Five-year collaboration aims to accelerate clinical development of select novel apoptosis-targeted and tyrosine kinase inhibitor product candidates The University of Texas MD Anderson Cancer Center...




